{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T18:23:32Z","timestamp":1794248612856,"version":"4.9.0"},"reference-count":136,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.isci.2026.116865","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:44:22Z","timestamp":1784591062000},"page":"116865","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antiretroviral regimen and sex-specific metabolic heterogeneity in pediatric HIV"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9668-8369","authenticated-orcid":false,"given":"Chandre","family":"Herbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole H.","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate","family":"Strehlau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faeezah","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace M.","family":"Aldrovandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline T.","family":"Tiemessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.116865_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/COH.0000000000000807","article-title":"Impact of early antiretroviral therapy, early life immunity and immune sex differences on HIV disease and posttreatment control in children","volume":"18","author":"Herbert","year":"2023","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.isci.2026.116865_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11904-022-00607-z","article-title":"Viral and Host Biomarkers of HIV Remission Post Treatment Interruption","volume":"19","author":"Giron","year":"2022","journal-title":"Curr. HIV AIDS Rep."},{"key":"10.1016\/j.isci.2026.116865_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03444-20","article-title":"Phospholipid Metabolism Is Associated with Time to HIV Rebound upon Treatment Interruption","volume":"12","author":"Giron","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.isci.2026.116865_bib4","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1517\/17425255.3.4.583","article-title":"The role of cytochrome P450 in antiretroviral drug interactions","volume":"3","author":"Walubo","year":"2007","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.isci.2026.116865_bib5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1146\/annurev-pharmtox-021320-111248","article-title":"Pharmacogenomics of Antiretroviral Drug Metabolism and Transport","volume":"61","author":"Yu","year":"2021","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.isci.2026.116865_bib6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s40262-016-0456-6","article-title":"Genetic Polymorphisms Affecting the Pharmacokinetics of Antiretroviral Drugs","volume":"56","author":"Calcagno","year":"2017","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.isci.2026.116865_bib7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3390\/tropicalmed9040074","article-title":"Adults with Perinatally Acquired HIV; Emerging Clinical Outcomes and Data Gaps","volume":"9","author":"Henderson","year":"2024","journal-title":"Trop. Med. Infect. Dis."},{"key":"10.1016\/j.isci.2026.116865_bib8","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/COH.0000000000000872","article-title":"Cardiovascular health in people with perinatally acquired HIV - where do we stand?","volume":"19","author":"Majonga","year":"2024","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.isci.2026.116865_bib9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/COH.0000000000000886","article-title":"Bridging the gaps in perinatal HIV: treatment and prevention","volume":"19","author":"Foster","year":"2024","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.isci.2026.116865_bib10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12967-025-06168-0","article-title":"Multi-omics dissection of metabolic dysregulation associated with immune recovery in people living with HIV-1","volume":"23","author":"Wan","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.isci.2026.116865_bib11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11904-018-0383-2","article-title":"Sex Differences in HIV Infection","volume":"15","author":"Scully","year":"2018","journal-title":"Curr. HIV AIDS Rep."},{"key":"10.1016\/j.isci.2026.116865_bib12","article-title":"Sex-specific innate immune selection of HIV-1 in utero is associated with increased female susceptibility to infection","volume":"11","author":"Adland","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.116865_bib13","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/s41467-025-56116-1","article-title":"Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies","volume":"16","author":"Gunst","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.116865_bib14","doi-asserted-by":"crossref","first-page":"e700","DOI":"10.1016\/S2352-3018(24)00157-7","article-title":"Analytical treatment interruption in children living with HIV: position statement from the EPIICAL consortium","volume":"11","author":"Kuhn","year":"2024","journal-title":"Lancet HIV"},{"key":"10.1016\/j.isci.2026.116865_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238316","article-title":"Plasma metabolomic study in perinatally HIV-infected children using 1H NMR spectroscopy reveals perturbed metabolites that sustain during therapy","volume":"15","author":"Kaur","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.116865_bib16","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1093\/jac\/dkab277","article-title":"Early antiretroviral therapy initiation effect on metabolic profile in vertically HIV-1-infected children","volume":"76","author":"Taranc\u00f3n-Diez","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.isci.2026.116865_bib17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/COH.0000000000000450","article-title":"Growth and pubertal development in HIV-infected adolescents","volume":"13","author":"Williams","year":"2018","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.isci.2026.116865_bib18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1753-4887.2009.00207.x","article-title":"Patterns of postnatal growth in HIV-infected and Hiv-exposed children","volume":"67","author":"Isanaka","year":"2009","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.isci.2026.116865_bib19","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1097\/QAD.0000000000002990","article-title":"Persistently lower bone mass and bone turnover among South African children living with well controlled HIV","volume":"35","author":"Shen","year":"2021","journal-title":"AIDS"},{"key":"10.1016\/j.isci.2026.116865_bib20","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/cid\/cix335","article-title":"Switching to Efavirenz Versus Remaining on Ritonavir-boosted Lopinavir in Human Immunodeficiency Virus-infected Children Exposed to Nevirapine: Long-term Outcomes of a Randomized Trial","volume":"65","author":"Murnane","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.isci.2026.116865_bib21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0166-3542(01)00148-6","article-title":"Metabolic complications associated with antiretroviral therapy","volume":"51","author":"Jain","year":"2001","journal-title":"Antiviral Res."},{"key":"10.1016\/j.isci.2026.116865_bib22","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2147\/HIV.S275314","article-title":"Antiretroviral Therapy-Associated Metabolic Complications: Review of the Recent Studies","volume":"12","author":"Thet","year":"2020","journal-title":"HIV AIDS Res. Palliat. Care"},{"key":"10.1016\/j.isci.2026.116865_bib23","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jaci.2003.07.003","article-title":"Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study","volume":"112","author":"Shearer","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.isci.2026.116865_bib24","series-title":"Steroid Biochemistry","author":"Hobkirk","year":"1979"},{"key":"10.1016\/j.isci.2026.116865_bib120","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/COH.0000000000000918","article-title":"Human models that inform antiretroviral therapy-free remission with perinatally acquired HIV infection","volume":"20","author":"Tiemessen","year":"2025","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.isci.2026.116865_bib25","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/cid\/ciab586","article-title":"Predictors of Cell-Associated Human Immunodeficiency Virus (HIV)-1 DNA Over 1 Year in Very Early Treated Infants","volume":"74","author":"Kuhn","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.isci.2026.116865_bib26","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1093\/infdis\/jiab223","article-title":"Early Initiation of Antiretroviral Therapy Following In Utero HIV Infection Is Associated With Low Viral Reservoirs but Other Factors Determine Viral Rebound","volume":"224","author":"Millar","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.isci.2026.116865_bib27","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1016\/S2352-3018(23)00236-9","article-title":"HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1\/2 proof-of-concept study","volume":"11","author":"Persaud","year":"2024","journal-title":"Lancet HIV"},{"key":"10.1016\/j.isci.2026.116865_bib28","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.3390\/nu10111564","article-title":"Glutamine: Metabolism and Immune Function, Supplementation and Clinical Translation","volume":"10","author":"Cruzat","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.isci.2026.116865_bib29","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1089\/aid.2017.0165","article-title":"Evidence for Altered Glutamine Metabolism in Human Immunodeficiency Virus Type 1 Infected Primary Human CD4+T Cells","volume":"33","author":"Hegedus","year":"2017","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.isci.2026.116865_bib30","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s42003-023-04975-z","article-title":"Elevated glutamate impedes anti-HIV-1 CD8 + T cell responses in HIV-1-infected individuals on antiretroviral therapy","volume":"6","author":"Wang","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.isci.2026.116865_bib31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3389\/fcimb.2020.00261","article-title":"The Glutamate System as a Crucial Regulator of CNS Toxicity and Survival of HIV Reservoirs","volume":"10","author":"Gorska","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.isci.2026.116865_bib32","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/pr.2016.115","article-title":"Bilirubin isomer distribution in jaundiced neonates during phototherapy with LED light centered at 497 nm (turquoise) vs. 459 nm (blue)","volume":"80","author":"Ebbesen","year":"2016","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.isci.2026.116865_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078146","article-title":"Distinct Tryptophan Catabolism and Th17\/Treg Balance in HIV Progressors and Elite Controllers","volume":"8","author":"Jenabian","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.116865_bib34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3390\/metabo12010061","article-title":"Metabolome Genome-Wide Association Study Identifies 74 Novel Genomic Regions Influencing Plasma Metabolites Levels","volume":"12","author":"Hysi","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.isci.2026.116865_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-29143-5","article-title":"Genome-wide association studies of metabolites in Finnish men identify disease-relevant loci","volume":"13","author":"Yin","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.116865_bib36","article-title":"Lipid metabolism-associated metabolites on cardiovascular diseases: a two-sample Mendelian randomized study","volume":"12","author":"Chen","year":"2025","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.isci.2026.116865_bib37","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1097\/00002030-200211220-00009","article-title":"Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs","volume":"16","author":"Huisman","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.isci.2026.116865_bib38","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.curtheres.2014.05.002","article-title":"Substantial effect of efavirenz monotherapy on bilirubin levels in healthy volunteers","volume":"76","author":"Metzger","year":"2014","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"10.1016\/j.isci.2026.116865_bib39","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/jpids\/pix026","article-title":"Patterns of Growth, Body Composition, and Lipid Profiles in a South African Cohort of Human Immunodeficiency Virus-Infected and Uninfected Children: A Cross-Sectional Study","volume":"7","author":"Ramteke","year":"2018","journal-title":"J. Pediatric Infect. Dis. Soc."},{"key":"10.1016\/j.isci.2026.116865_bib40","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/09540121.2016.1224310","article-title":"Extent of disclosure: what perinatally HIV-infected children have been told about their own HIV status","volume":"29","author":"Murnane","year":"2017","journal-title":"AIDS Care"},{"key":"10.1016\/j.isci.2026.116865_bib41","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/QAI.0000000000002265","article-title":"Negative Diagnostic PCR Tests in School-Aged, HIV-Infected Children on Antiretroviral Therapy Since Early Life in Johannesburg, South Africa","volume":"83","author":"Patel","year":"2020","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.isci.2026.116865_bib42","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/QAD.0000000000003599","article-title":"Microbiota in the oral cavity of school-age children with HIV who started antiretroviral therapy at young ages in South Africa","volume":"37","author":"Kuhn","year":"2023","journal-title":"AIDS"},{"key":"10.1016\/j.isci.2026.116865_bib43","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/09540121.2021.2017397","article-title":"Disclosure to South African children about their own HIV status over time","volume":"35","author":"Wu","year":"2023","journal-title":"AIDS Care"},{"key":"10.1016\/j.isci.2026.116865_bib44","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jpeds.2020.07.057","article-title":"Behavioral Functioning and Quality of Life in South African Children Living with HIV on Antiretroviral Therapy","volume":"227","author":"Shiau","year":"2020","journal-title":"J. Pediatr."},{"key":"10.1016\/j.isci.2026.116865_bib45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/aid.2018.0182","article-title":"Mitochondrial Impairment in Well-Suppressed Children with Perinatal HIV-Infection on Antiretroviral Therapy","volume":"36","author":"Shen","year":"2020","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.isci.2026.116865_bib46","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1097\/QAD.0000000000001204","article-title":"Efavirenz is associated with higher bone mass in South African children with HIV","volume":"30","author":"Arpadi","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/j.isci.2026.116865_bib47","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s11904-023-00657-x","article-title":"The human microbiome and gut\u2013liver axis in people living with HIV","volume":"20","author":"Duarte","year":"2023","journal-title":"Curr. HIV AIDS Rep."},{"key":"10.1016\/j.isci.2026.116865_bib48","first-page":"7","article-title":"The role of CYP3A4 in the biotransformation of bile acids and therapeutic implication for cholestasis","volume":"2","author":"Chen","year":"2014","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.isci.2026.116865_bib49","doi-asserted-by":"crossref","first-page":"9866","DOI":"10.3390\/ijms23179866","article-title":"The Mechanism-Based Inactivation of CYP3A4 by Ritonavir: What Mechanism?","volume":"23","author":"Loos","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.116865_bib50","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1211\/002235702739","article-title":"Apparent mechanism-based inhibition of human CYP3A in-vitro by lopinavir","volume":"55","author":"Weemhoff","year":"2003","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.isci.2026.116865_bib51","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1177\/0091270004269142","article-title":"Induction of CYP3A4 by Efavirenz in Primary Human Hepatocytes: Comparison With Rifampin and Phenobarbital","volume":"44","author":"Hariparsad","year":"2004","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.isci.2026.116865_bib52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41392-024-01811-6","article-title":"Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets","volume":"9","author":"Fleishman","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.isci.2026.116865_bib53","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.3390\/microorganisms10091792","article-title":"Bile Acids: Major Regulator of the Gut Microbiome","volume":"10","author":"An","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.isci.2026.116865_bib54","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41522-024-00566-w","article-title":"Effects of bile acids on the growth, composition and metabolism of gut bacteria","volume":"10","author":"Peng","year":"2024","journal-title":"NPJ Biofilms Microbiomes"},{"key":"10.1016\/j.isci.2026.116865_bib55","article-title":"The gut microbiota\u2013bile acid axis: A potential therapeutic target for liver fibrosis","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.isci.2026.116865_bib56","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/COH.0000000000000428","article-title":"Impact of antiretroviral drugs on the microbiome: unknown answers to important questions","volume":"13","author":"Pinto-Cardoso","year":"2018","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.isci.2026.116865_bib57","article-title":"In vitro antibacterial activity of antiretroviral drugs on key commensal bacteria from the human microbiota","volume":"13","author":"Rubio-Garcia","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.isci.2026.116865_bib58","doi-asserted-by":"crossref","DOI":"10.7448\/IAS.20.1.21526","article-title":"Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients","volume":"20","author":"Villanueva-Mill\u00e1n","year":"2017","journal-title":"J. Int. AIDS Soc."},{"key":"10.1016\/j.isci.2026.116865_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.639291","article-title":"Long-Term Suppressive cART Is Not Sufficient to Restore Intestinal Permeability and Gut Microbiota Compositional Changes","volume":"12","author":"Ancona","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.116865_bib60","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s40121-022-00654-4","article-title":"Integrase Inhibitors Partially Restore Bacterial Translocation, Inflammation and Gut Permeability Induced by HIV Infection: Impact on Gut Microbiota","volume":"11","author":"Villoslada-Blanco","year":"2022","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.isci.2026.116865_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11040951","article-title":"Gut Bacterial Communities in HIV-Infected Individuals with Metabolic Syndrome: Effects of the Therapy with Integrase Strand Transfer Inhibitor-Based and Protease Inhibitor-Based Regimens","volume":"11","author":"Baltazar-D\u00edaz","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.isci.2026.116865_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-68479-4","article-title":"Exploring the interplay between antiretroviral therapy and the gut-oral microbiome axis in people living with HIV","volume":"14","author":"Narayanan","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.116865_bib63","doi-asserted-by":"crossref","first-page":"7666","DOI":"10.1038\/s41598-021-87368-8","article-title":"Alteration of the gut fecal microbiome in children living with HIV on antiretroviral therapy in Yaounde, Cameroon","volume":"11","author":"Abange","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.116865_bib64","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00238-24","article-title":"Analysis of the gut microbiota and fecal metabolites in people living with HIV","volume":"12","author":"Tian","year":"2024","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.isci.2026.116865_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.723840","article-title":"Gut Microbiota and Fecal Metabolites Associated With Neurocognitive Impairment in HIV-Infected Population","volume":"11","author":"Dong","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.isci.2026.116865_bib66","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/s41385-019-0162-4","article-title":"Emerging roles of bile acids in mucosal immunity and inflammation","volume":"12","author":"Chen","year":"2019","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.isci.2026.116865_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202250299","article-title":"Bile acid-activated receptors in innate and adaptive immunity: targeted drugs and biological agents","volume":"53","author":"Cheung","year":"2023","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.isci.2026.116865_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.949033","article-title":"Bile acids in immunity: Bidirectional mediators between the host and the microbiota","volume":"13","author":"Godlewska","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.116865_bib69","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/clpt.2012.34","article-title":"Compartment-Specific Gene Regulation of the CAR Inducer Efavirenz In Vivo","volume":"92","author":"Meyer Zu Schwabedissen","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.isci.2026.116865_bib70","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/jac\/dkl238","article-title":"Association of total bilirubin with indinavir and lopinavir plasma concentrations in HIV-infected patients receiving three different double-boosted dosing regimens","volume":"58","author":"Dicenzo","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.isci.2026.116865_bib71","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/apc.2011.0092","article-title":"Clinical Significance of Hyperbilirubinemia Among HIV-1\u2013Infected Patients Treated with Atazanavir\/Ritonavir Through 96 Weeks in the CASTLE Study","volume":"26","author":"McDonald","year":"2012","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.isci.2026.116865_bib72","article-title":"The metabolomic profiling of total fat and fat distribution in a multi-cohort study of women and men","volume":"13","author":"Zheng","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.116865_bib73","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1158\/1055-9965.EPI-20-0187","article-title":"Serum Metabolomic Response to Low- and High-Dose Vitamin E Supplementation in Two Randomized Controlled Trials","volume":"29","author":"Huang","year":"2020","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.isci.2026.116865_bib74","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/oby.23441","article-title":"A multivariant recall-by-genotype study of the metabolomic signature of BMI","volume":"30","author":"Fang","year":"2022","journal-title":"Obesity"},{"key":"10.1016\/j.isci.2026.116865_bib75","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1210\/clinem\/dgaa693","article-title":"The Plasma Metabolomic Profile is Differently Associated with Liver Fat, Visceral Adipose Tissue, and Pancreatic Fat","volume":"106","author":"Lind","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2026.116865_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101342","article-title":"Metabolomic architecture of obesity implicates metabolonic lactone sulfate in cardiometabolic disease","volume":"54","author":"Das","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.isci.2026.116865_bib77","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11306-019-1519-0","article-title":"Exposure to disinfection byproducts and risk of type 2 diabetes: a nested case\u2013control study in the HUNT and Lifelines cohorts","volume":"15","author":"G\u00e4ngler","year":"2019","journal-title":"Metabolomics"},{"key":"10.1016\/j.isci.2026.116865_bib78","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1007\/s00125-017-4325-0","article-title":"Early metabolic markers identify potential targets for the prevention of type 2 diabetes","volume":"60","author":"Peddinti","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.isci.2026.116865_bib79","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3390\/metabo9100210","article-title":"Plasma Metabolic Signature and Abnormalities in HIV-Infected Individuals on Long-Term Successful Antiretroviral Therapy","volume":"9","author":"Babu","year":"2019","journal-title":"Metabolites"},{"key":"10.1016\/j.isci.2026.116865_bib80","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/s41588-023-01409-8","article-title":"Genetic studies of paired metabolomes reveal enzymatic and transport processes at the interface of plasma and urine","volume":"55","author":"Schlosser","year":"2023","journal-title":"Nat. Genet."},{"key":"10.1016\/j.isci.2026.116865_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.905773","article-title":"Contribution of Sex Differences to HIV Immunology, Pathogenesis, and Cure Approaches","volume":"13","author":"Moran","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.116865_bib82","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cca.2016.07.022","article-title":"Serum levels of cholesterol, pregnenolone, DHEA, and their sulfate conjugates based on sex and pubertal stage in adolescents","volume":"461","author":"Kim","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.isci.2026.116865_bib83","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1210\/clinem\/dgae008","article-title":"Update on Adrenarche\u2014Still a Mystery","volume":"109","author":"Augsburger","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2026.116865_bib84","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1530\/JOE-12-0183","article-title":"The steroid metabolome of adrenarche","volume":"214","author":"Rege","year":"2012","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.isci.2026.116865_bib85","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1210\/jc.2005-0036","article-title":"Iatrogenic Cushing\u2019s Syndrome with Osteoporosis and Secondary Adrenal Failure in Human Immunodeficiency Virus-Infected Patients Receiving Inhaled Corticosteroids and Ritonavir-Boosted Protease Inhibitors: Six Cases","volume":"90","author":"Samaras","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2026.116865_bib86","article-title":"Acute development of Cushing syndrome in an HIV-infected child on atazanavir\/ritonavir based antiretroviral therapy","volume":"2017","author":"Dubrocq","year":"2017","journal-title":"Endocrinol. Diabetes Metab. Case Rep."},{"key":"10.1016\/j.isci.2026.116865_bib87","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000500522","article-title":"HIV Drug Efavirenz Inhibits CYP21A2 Activity with Possible Clinical Implications","volume":"91","author":"Malikova","year":"2019","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.isci.2026.116865_bib88","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1210\/er.2018-00097","article-title":"Glucocorticoids and Bone: Consequences of Endogenous and Exogenous Excess and Replacement Therapy","volume":"39","author":"Hardy","year":"2018","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.isci.2026.116865_bib89","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1471-2334-13-203","article-title":"Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors","volume":"13","author":"Cassol","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.isci.2026.116865_bib90","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1097\/QAI.0000000000001159","article-title":"Nanoflow-Nanospray Mass Spectrometry Metabolomics Reveals Disruption of the Urinary Metabolite Profiles of HIV-Positive Patients on Combination Antiretroviral Therapy","volume":"74","author":"Chetwynd","year":"2017","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.isci.2026.116865_bib91","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/hep.23647","article-title":"Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells","volume":"52","author":"Blas-Garc\u00eda","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2026.116865_bib92","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.redox.2014.03.003","article-title":"Bypassing the compromised mitochondrial electron transport with methylene blue alleviates efavirenz\/isoniazid-induced oxidant stress and mitochondria-mediated cell death in mouse hepatocytes","volume":"2","author":"Lee","year":"2014","journal-title":"Redox Biol."},{"key":"10.1016\/j.isci.2026.116865_bib93","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.redox.2015.01.005","article-title":"Mechanisms of cell death pathway activation following drug-induced inhibition of mitochondrial complex I","volume":"4","author":"Imaizumi","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.isci.2026.116865_bib94","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1093\/jac\/dkv183","article-title":"Efavirenz and the CNS: what we already know and questions that need to be answered","volume":"70","author":"Apostolova","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.isci.2026.116865_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005461","article-title":"The promiscuous enzyme medium-chain 3-keto-acyl-CoA thiolase triggers a vicious cycle in fatty-acid beta-oxidation","volume":"13","author":"Martines","year":"2017","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.isci.2026.116865_bib96","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12012-015-9314-2","article-title":"Efavirenz Causes Oxidative Stress, Endoplasmic Reticulum Stress, and Autophagy in Endothelial Cells","volume":"16","author":"Wei\u00df","year":"2016","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.isci.2026.116865_bib97","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.it.2024.02.002","article-title":"Unlocking potential: the role of the electron transport chain in immunometabolism","volume":"45","author":"Zotta","year":"2024","journal-title":"Trends Immunol."},{"key":"10.1016\/j.isci.2026.116865_bib98","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/jac\/dkl348","article-title":"Intracellular and plasma efavirenz concentrations in HIV-infected patients switching from successful protease inhibitor-based highly active antiretroviral therapy (HAART) to efavirenz-based HAART (SUSTIPHAR Study)","volume":"58","author":"Djabarouti","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.isci.2026.116865_bib99","first-page":"356","article-title":"An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3\u2032-UTR Single Nucleotide Polymorphisms among Black South African HIV\/AIDS Patients","volume":"6","author":"Swart","year":"2015","journal-title":"Front. Genet."},{"key":"10.1016\/j.isci.2026.116865_bib100","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.3390\/molecules27041358","article-title":"The Effect of Antiretroviral Therapy on SIRT1, SIRT3 and SIRT6 Expression in HIV-Infected Patients","volume":"27","author":"Jurkowska","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.isci.2026.116865_bib101","doi-asserted-by":"crossref","first-page":"E191","DOI":"10.1152\/ajpendo.00405.2020","article-title":"Bilirubin as a metabolic hormone: the physiological relevance of low levels","volume":"320","author":"Creeden","year":"2021","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2026.116865_bib102","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1038\/s41598-018-24917-8","article-title":"Low Bilirubin Levels Indicate a High Risk of Cerebral Deep White Matter Lesions in Apparently Healthy Subjects","volume":"8","author":"Higuchi","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.116865_bib103","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab288","article-title":"HIV-Infected Individuals on ART With Impaired Immune Recovery Have Altered Plasma Metabolite Profiles","volume":"8","author":"Nystr\u00f6m","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.isci.2026.116865_bib104","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1161\/CIRCULATIONAHA.118.037487","article-title":"Elevated Plasma Ceramides Are Associated With Antiretroviral Therapy Use and Progression of Carotid Artery Atherosclerosis in HIV Infection","volume":"139","author":"Zhao","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.isci.2026.116865_bib105","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jamacardio.2019.4025","article-title":"Association of Lipidomic Profiles With Progression of Carotid Artery Atherosclerosis in HIV Infection","volume":"4","author":"Chai","year":"2019","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.isci.2026.116865_bib106","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s11904-019-00442-9","article-title":"Lipidome Abnormalities and Cardiovascular Disease Risk in HIV Infection","volume":"16","author":"Bowman","year":"2019","journal-title":"Curr. HIV AIDS Rep."},{"key":"10.1016\/j.isci.2026.116865_bib107","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12981-021-00383-7","article-title":"Acute myocardial infarction associated with abacavir and tenofovir based antiretroviral drug combinations in the United States","volume":"18","author":"Dorjee","year":"2021","journal-title":"AIDS Res. Ther."},{"key":"10.1016\/j.isci.2026.116865_bib108","first-page":"157","article-title":"Metabolic events in HIV-infected patients using abacavir are associated with erythrocyte inosine triphosphatase activity","volume":"74","author":"Peltenburg","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.isci.2026.116865_bib109","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1039\/C7MB00336F","article-title":"HIV\/HAART-associated oxidative stress is detectable by metabonomics","volume":"13","author":"Williams","year":"2017","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.isci.2026.116865_bib110","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1039\/C2MB25318F","article-title":"Metabonomic analysis of HIV-infected biofluids","volume":"9","author":"Sitole","year":"2013","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.isci.2026.116865_bib111","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.692823","article-title":"Metabolomics as a tool to investigate HIV\/TB co-infection","volume":"8","author":"Liebenberg","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.isci.2026.116865_bib112","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3390\/v16040582","article-title":"Cardiometabolic Differences in People Living with HIV Receiving Integrase Strand Transfer Inhibitors Compared to Non-nucleoside Reverse Transcriptase Inhibitors: Implications for Current ART Strategies","volume":"16","author":"Vos","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2026.116865_bib113","doi-asserted-by":"crossref","DOI":"10.3390\/v16091462","article-title":"Comparative Effects of Efavirenz and Dolutegravir on Metabolomic and Inflammatory Profiles, and Platelet Activation of People Living with HIV: A Pilot Study","volume":"16","author":"Roux","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2026.116865_bib114","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1093\/infdis\/jiac175","article-title":"Dolutegravir Suppresses Thermogenesis via Disrupting Uncoupling Protein 1 Expression and Mitochondrial Function in Brown\/Beige Adipocytes in Preclinical Models","volume":"226","author":"Jung","year":"2022","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.isci.2026.116865_bib115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/QAD.0000000000003369","article-title":"Dolutegravir-containing HIV therapy reversibly alters mitochondrial health and morphology in cultured human fibroblasts and peripheral blood mononuclear cells","volume":"37","author":"Ajaykumar","year":"2023","journal-title":"AIDS"},{"key":"10.1016\/j.isci.2026.116865_bib116","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s40121-024-00943-0","article-title":"Distinct Lipidomic Profiles between People Living with HIV Treated with E\/C\/F\/TAF or B\/F\/TAF: An Open-Label Prospective Cohort Study","volume":"13","author":"Wan","year":"2024","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.isci.2026.116865_bib117","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000026588","article-title":"Changes in lipidomic profile by anti-retroviral treatment regimen: An ACTG 5257 ancillary study","volume":"100","author":"Chaudhary","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.isci.2026.116865_bib118","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-53761-7","article-title":"Similar plasma lipidomic profile in people living with HIV treated with a darunavir-based or an integrase inhibitor-based antiretroviral therapy","volume":"9","author":"Mena","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.116865_bib119","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1177\/135965350701200704","article-title":"Mitochondrial Toxicity of Tenofovir, Emtricitabine and Abacavir Alone and in Combination with Additional Nucleoside Reverse Transcriptase Inhibitors","volume":"12","author":"Venhoff","year":"2007","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.isci.2026.116865_bib121","series-title":"R: A Language and Environment for Statistical Computing","year":"2022"},{"key":"10.1016\/j.isci.2026.116865_bib122","doi-asserted-by":"crossref","first-page":"W652","DOI":"10.1093\/nar\/gkp356","article-title":"MetaboAnalyst: a web server for metabolomic data analysis and interpretation","volume":"37","author":"Xia","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2026.116865_bib123","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the Tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J. Open Source Softw."},{"key":"10.1016\/j.isci.2026.116865_bib124","author":"Kassambara"},{"key":"10.1016\/j.isci.2026.116865_bib125","author":"Kassambara"},{"key":"10.1016\/j.isci.2026.116865_bib126","series-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2016"},{"key":"10.1016\/j.isci.2026.116865_bib127","series-title":"Interactive Web-Based Data Visualization with R, Plotly, and Shiny","author":"Sievert","year":"2020"},{"key":"10.1016\/j.isci.2026.116865_bib128","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.21105\/joss.03167","article-title":"Visualizations with statistical details: The 'ggstatsplot' approach","volume":"6","author":"Patil","year":"2021","journal-title":"J. Open Source Softw."},{"key":"10.1016\/j.isci.2026.116865_bib129","author":"Gao"},{"key":"10.1016\/j.isci.2026.116865_bib130","unstructured":"Blighe K, Rana, S., Lewis, M. EnhancedVolcano: Publication-Ready Volcano Plots with Enhanced Colouring and Labeling. 1., ed2022."},{"key":"10.1016\/j.isci.2026.116865_bib131","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1021\/es5002105","article-title":"Identifying Small Molecules via High Resolution Mass Spectrometry: Communicating Confidence","volume":"48","author":"Schymanski","year":"2014","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.isci.2026.116865_bib132","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ptsp.2018.07.009","article-title":"The use of nonparametric effect sizes in single study musculoskeletal physiotherapy research: A practical primer","volume":"33","author":"Pautz","year":"2018","journal-title":"Phys. Ther. Sport"},{"key":"10.1016\/j.isci.2026.116865_bib133","first-page":"19","article-title":"The need to report effect size estimates revisited. An overview of some recommended measures of effect size","volume":"21","author":"Tomczak","year":"2014","journal-title":"Trends Sport Sci."},{"key":"10.1016\/j.isci.2026.116865_bib134","series-title":"Discovering Statistics Using IBM SPSS Statistics","author":"Field","year":"2013"},{"key":"10.1016\/j.isci.2026.116865_bib135","author":"Signorell"},{"key":"10.1016\/j.isci.2026.116865_bib136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v042.i08","article-title":"MatchIt: Nonparametric Preprocessing for Parametric Causal Inference","volume":"42","author":"Ho","year":"2011","journal-title":"J. Stat. Softw."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226022431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226022431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T18:01:26Z","timestamp":1794247286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226022431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":136,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2589004226022431"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.116865","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiretroviral regimen and sex-specific metabolic heterogeneity in pediatric HIV","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.116865","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116865"}}